1. Heart disease and stroke statistics—2016 update. A report from the American Heart Association;Mozaffarian,2016
2. Scientific rationale for the Inclusion and exclusion criteria for intravenous Alteplase in acute ischemic stroke. A statement for Healthcare Professionals from the American Heart Association/American Stroke Association;Demaerschalk,2016
3. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment. A guideline for healthcare professionals from the American Heart Association/American Stroke Association;Powers,2015
4. Tissue plasminogen activator for acute ischemic stroke;Disorders, T.N.I.o.N. and S.r.-P.S.S. Group;N Engl J Med,1995
5. Wardlaw, J.M., et al., Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 379(9834): p. 2364–2372.